Key statistics
As of last trade IMCD NV (IMCDY:PKL) traded at 72.80, 5.74% above its 52-week low of 68.85, set on Jul 02, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 72.93 |
---|---|
High | 73.04 |
Low | 71.74 |
Bid | -- |
Offer | -- |
Previous close | 71.89 |
Average volume | 21.98k |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Annual div (ADY) | 1.21 USD |
---|---|
Annual div yield (ADY) | 1.69% |
Div ex-date | May 16 2024 |
Div pay-date | Jun 05 2024 |
Data delayed at least 15 minutes, as of Nov 22 2024 18:57 GMT.
More ▼
- IMCD N.V. successfully raises EUR 300 million through an accelerated bookbuild offering of new shares
- IMCD N.V. LAUNCHES A CAPITAL RAISE OF EUR 300 MILLION TO INCREASE FINANCIAL FLEXIBILITY
- IMCD reports EBITA of EUR 403 million in the first nine months of 2024
- IMCD acquires Blumos Group to accelerate its growth in the life science markets in Latin America
- IMCD successfully issues a EUR 500 million rated bond
- IMCD reports EBITA of EUR 270 million in the first half of 2024
- IMCD Italy expands its Pharmaceuticals presence with the acquisition of Selechimica
- Shareholders IMCD N.V. adopt all resolutions at AGM
- IMCD reports EBITA of EUR 127 million in the first three months of 2024
- IMCD Spain expands its Pharmaceuticals presence with the acquisition of Cobapharma
More ▼